| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.308 | 19.893 | 49.112 | 52.437 | 73.371 | 118.332 | 94.515 |
| Total Income - EUR | - | - | - | 6.841 | 43.381 | 49.129 | 64.400 | 73.274 | 117.006 | 96.477 |
| Total Expenses - EUR | - | - | - | 5.255 | 37.422 | 23.355 | 32.387 | 54.490 | 69.034 | 65.560 |
| Gross Profit/Loss - EUR | - | - | - | 1.586 | 5.959 | 25.774 | 32.013 | 18.784 | 47.971 | 30.917 |
| Net Profit/Loss - EUR | - | - | - | 1.457 | 5.363 | 24.379 | 30.773 | 17.418 | 46.966 | 28.855 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Cardioscience S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 19.554 | 27.706 | 38.309 | 30.697 | 49.221 | 112.467 |
| Current Assets | - | - | - | 6.703 | 15.800 | 21.694 | 24.298 | 9.577 | 36.421 | 23.283 |
| Inventories | - | - | - | 2.626 | 6.840 | 1.878 | 2.829 | 2.722 | 1.374 | 572 |
| Receivables | - | - | - | 4.009 | 310 | 1.892 | 255 | 996 | 7.511 | 6.312 |
| Cash | - | - | - | 68 | 8.651 | 17.924 | 21.214 | 5.859 | 27.536 | 16.399 |
| Shareholders Funds | - | - | - | 1.542 | 6.876 | 31.124 | 61.207 | 37.192 | 75.384 | 126.682 |
| Social Capital | - | - | - | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | 5.161 | 28.478 | 16.274 | 1.399 | 3.083 | 10.258 | 9.068 |
| Income in Advance | - | - | - | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Cardioscience S.r.l.